GVN adds EVIT Center and Chumakov as its new Centers of Excellence
By Akshay Kedari  Date: 2020-09-10

GVN adds EVIT Center and Chumakov as its new Centers of Excellence

The Global Virus Network (GVN), an international coalition of medical virologists, has recently announced the addition of Australian and Russian researchers.

GVN is adding the Center for EVIT (Emerging Viruses, Inflammation & Therapeutics) of the MHIQ (Menzies Health Institute Queensland) at Griffith University, Australia & the Chumakov FSC R&D IBP (Federal Scientific Center for the Research & Development of Immune & Biological Products) for the RAS (Russian Academy of Sciences) as its new Centers of Excellence.

The recently added two new institutions will bring the total strength of GVN’s Center of Excellence to 57, including 10 affiliates in 33 countries.

According to Christian Brechot, MD, Ph.D., President of the GVN, the company is excited to welcome the premier institutions from Russia and Australia amid the COVID-19 pandemic. He added that the addition of EVIT will help strengthen its collaborative network in arbovirology across APAC, Southeast Asia, South America, South Africa, and India.

EVIT consists of a wide range of clinicians and scientists with high expertise in arbovirus diseases, enhanced knowledge of viral pathogenesis as well as other related inflammatory diseases. The Center is also capable of developing treatment for chikungunya, dengue, Japanese encephalitis, and other emerging viruses. It is currently focusing on SARS-CoV-2, Hendra, influenza, and other established viruses.

Dr. Suresh Mahalingam, Professor and Director at GVN Center, has stated that the center can significantly contribute to world health, which will help open up additional collaboration opportunities for its research center. Through its GVN membership, it is planning to enhance the leadership position in arbovirus R&D preparedness in the APAC region.

On the other hand, the Chumakov Center conducts multiple studies on viruses and vaccines, supplying over 70% of the demand in Russia. The center contains the WHO’s regional reference laboratory for polio performing AFP (acute flaccid paralysis) surveillance as well as polio as a part of GPLN (Global Polio Laboratory Network) of GPEI (Global Polio Eradication Initiative). Additionally, it acts as the WHO Collaborative Center for the Poliomyelitis & Enterovirus Surveillance & Research.

Source credit:

https://www.prnewswire.com/news-releases/prominent-australian-and-russian-research-institutions-join-global-virus-network-to-combat-viral-diseases-301126520.html

About Author

Akshay Kedari    

Akshay Kedari

A qualified computer engineering graduate, Akshay Kedari takes pride in having his way with words. Following his passion for content creation, he writes insightful pieces on aeresearch.net and a few other portals. Also endorsed with a short-term experience in web deve...

Read More

More News By Akshay Kedari

Fibonacci Brands acquires Darwin from Harvest Health & Recreation
Fibonacci Brands acquires Darwin from Harvest Health & Recreation
By Akshay Kedari

Fibonacci Brands has recently announced the acquisition of Darwin from Harvest Health & Recreation (HARV.CN) as its foundation brand. Fibonacci is a leading player in the international cannabis industry. According to James George, founder of Fib...

Wind Point Partners takes over RTIC to expand business portfolio
Wind Point Partners takes over RTIC to expand business portfolio
By Akshay Kedari

American private equity firm, Wind Point Partners has recently signed an acquisition deal with the one of the biggest direct-to-consumer (D2C) eCommerce providers of drinkware, RTIC. Reportedly, RTIC is Wind Point’s third acquisition of a famil...

Novartis reveals positive data from Phase III ORION trials of inclisiran
Novartis reveals positive data from Phase III ORION trials of inclisiran
By Akshay Kedari

Swiss multinational pharmaceutical firm, Novartis has recently announced results from its Phase III ORION-10 and -11 studies that focus on assessing the individual responses of patients on lowering low-density lipoprotein cholesterol (LDL-C) with inc...

Medtronic to acquire Companion Medical to expand diabetes business
Medtronic to acquire Companion Medical to expand diabetes business
By Akshay Kedari

Medtronic plc, the global leader in medical technologies, has reportedly announced that it is planning to acquire insulin pen manufacturer Companion Medical. The acquisition gives Medtronic access to Companion Medical’s ‘InPen’, wh...

RADCOM introduces automated assurance solution for 5G technology
RADCOM introduces automated assurance solution for 5G technology
By Akshay Kedari

5G technology has been in the headlines for quite a while. Next-generation technology has the potential to transform almost every sector across the world. However, as 5G becomes reality, it has become imperative for service providers to prevent degra...